Figure 2.

Disease‐specific survival of gastric cancer patients according to the Kaplan‐Meier method. A, Low versus high matrix metalloproteinase 14 (MMP14) expression. B, Negative vs positive nuclear prospero homeobox protein 1 (PROX1) expression. Low vs high MMP14 expression among patients with (C) a negative nuclear PROX1 expression, (D) a low cytoplasmic PROX1 expression, (E) a positive nuclear PROX1 expression, (F) a high cytoplasmic PROX1 expression, (G) intestinal‐type, and (H) diffuse‐type tumors. P value calculated using the log‐rank test